Activity Detection of GalNAc Transferases by Protein-Based Fluorescence Sensors In Vivo

Lina Song1, Collin Bachert1, Adam D Linstedt2

  • 1Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.

Insights

Researchers developed novel protein-based fluorescence sensors to monitor GalNAc-transferase activity in living cells. This advancement aids in understanding mucin-type O-glycosylation, a critical posttranslational modification linked to human diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Mucin-type O-glycosylation is a key posttranslational modification occurring in the Golgi apparatus.
  • This process is initiated by up to 20 N-acetylgalactosaminyltransferase (GalNAc-transferase) isozymes with distinct substrate specificities.
  • Dysregulation of GalNAc-transferase activity is implicated in various human diseases.

Purpose of the Study:

  • To develop novel tools for monitoring GalNAc-transferase activity in real-time within living cells.
  • To investigate the role of specific GalNAc-transferase isozymes in cellular processes.
  • To provide a method for studying the impact of glycosylation pathway misregulation.

Main Methods:

  • Utilized protein-based fluorescence sensors engineered to traffic within the secretory pathway.
  • Designed sensors for broad (pan) GalNAc-transferase activity detection.
  • Developed isozyme-specific sensors for targeted activity monitoring.

Main Results:

  • Demonstrated the successful application of fluorescence sensors to monitor GalNAc-transferase activity in living cells.
  • Showcased the ability of sensors to differentiate between pan and isozyme-specific activities.
  • Validated the utility of these sensors for studying protein posttranslational modifications.

Conclusions:

  • Protein-based fluorescence sensors offer a powerful new method for assessing GalNAc-transferase activity in situ.
  • These sensors facilitate the study of mucin-type O-glycosylation and its role in health and disease.
  • The developed tools will advance research into glycosylation-related disorders.